111 related articles for article (PubMed ID: 38334275)
1. Implementation of a Hepatocellular Carcinoma Surveillance Program in a Community-Based Integrated Health System in Patients With Hepatitis C Cirrhosis.
Bui H; Kumar NG; Singal AG; Boparai J; Mukhtar NA; Tran D; Saxena V; Balasubramanian S
Am J Gastroenterol; 2024 Mar; ():. PubMed ID: 38334275
[TBL] [Abstract][Full Text] [Related]
2. Impact of nationwide hepatocellular carcinoma surveillance on the prognosis in patients with chronic liver disease.
Sohn W; Kang D; Kang M; Guallar E; Cho J; Paik YH
Clin Mol Hepatol; 2022 Oct; 28(4):851-863. PubMed ID: 36263667
[TBL] [Abstract][Full Text] [Related]
3. Compliance With Hepatocellular Carcinoma Surveillance Guidelines Associated With Increased Lead-Time Adjusted Survival of Patients With Compensated Viral Cirrhosis: A Multi-Center Cohort Study.
Costentin CE; Layese R; Bourcier V; Cagnot C; Marcellin P; Guyader D; Pol S; Larrey D; De Lédinghen V; Ouzan D; Zoulim F; Roulot D; Tran A; Bronowicki JP; Zarski JP; Riachi G; Calès P; Péron JM; Alric L; Bourlière M; Mathurin P; Blanc JF; Abergel A; Serfaty L; Mallat A; Grangé JD; Attali P; Bacq Y; Wartelle C; Dao T; Thabut D; Pilette C; Silvain C; Christidis C; Nguyen-Khac E; Bernard-Chabert B; Zucman D; Di Martino V; Sutton A; Letouzé E; Imbeaud S; Zucman-Rossi J; Audureau E; Roudot-Thoraval F; Nahon P;
Gastroenterology; 2018 Aug; 155(2):431-442.e10. PubMed ID: 29729258
[TBL] [Abstract][Full Text] [Related]
4. Surveillance improves survival of patients with hepatocellular carcinoma: a prospective population-based study.
Hong TP; Gow PJ; Fink M; Dev A; Roberts SK; Nicoll A; Lubel JS; Kronborg I; Arachchi N; Ryan M; Kemp WW; Knight V; Sundararajan V; Desmond P; Thompson AJ; Bell SJ
Med J Aust; 2018 Oct; 209(8):348-354. PubMed ID: 30309301
[TBL] [Abstract][Full Text] [Related]
5. HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: A meta-analysis.
Singal AG; Zhang E; Narasimman M; Rich NE; Waljee AK; Hoshida Y; Yang JD; Reig M; Cabibbo G; Nahon P; Parikh ND; Marrero JA
J Hepatol; 2022 Jul; 77(1):128-139. PubMed ID: 35139400
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of surveillance for hepatocellular carcinoma in clinical practice: A United States cohort.
Mittal S; Kanwal F; Ying J; Chung R; Sada YH; Temple S; Davila JA; El-Serag HB
J Hepatol; 2016 Dec; 65(6):1148-1154. PubMed ID: 27476765
[TBL] [Abstract][Full Text] [Related]
7. Regional Differences in Clinical Presentation and Prognosis of Patients With Post-Sustained Virologic Response Hepatocellular Carcinoma.
Toyoda H; Kanneganti M; Melendez-Torres J; Parikh ND; Jalal PK; Piñero F; Mendizabal M; Ridruejo E; Cheinquer H; Casadei-Gardini A; Weinmann A; Peck-Radosavljevic M; Dufour JF; Radu P; Shiha G; Soliman R; Sarin SK; Kumar M; Wang JH; Tangkijvanich P; Sukeepaisarnjaroen W; Atsukawa M; Uojima H; Nozaki A; Nakamuta M; Takaguchi K; Hiraoka A; Abe H; Matsuura K; Watanabe T; Shimada N; Tsuji K; Ishikawa T; Mikami S; Itobayashi E; Singal AG; Johnson PJ
Clin Gastroenterol Hepatol; 2024 Jan; 22(1):72-80.e4. PubMed ID: 37442316
[TBL] [Abstract][Full Text] [Related]
8. Early detection, curative treatment, and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis: a meta-analysis.
Singal AG; Pillai A; Tiro J
PLoS Med; 2014 Apr; 11(4):e1001624. PubMed ID: 24691105
[TBL] [Abstract][Full Text] [Related]
9. Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC.
Notarpaolo A; Layese R; Magistri P; Gambato M; Colledan M; Magini G; Miglioresi L; Vitale A; Vennarecci G; Ambrosio CD; Burra P; Di Benedetto F; Fagiuoli S; Colasanti M; Maria Ettorre G; Andreoli A; Cillo U; Laurent A; Katsahian S; Audureau E; Roudot-Thoraval F; Duvoux C
J Hepatol; 2017 Mar; 66(3):552-559. PubMed ID: 27899297
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular Carcinoma Surveillance Among Patients With Cirrhosis in a Population-based Integrated Health Care Delivery System.
Singal AG; Tiro J; Li X; Adams-Huet B; Chubak J
J Clin Gastroenterol; 2017 Aug; 51(7):650-655. PubMed ID: 27870642
[TBL] [Abstract][Full Text] [Related]
11. Hepatocellular Carcinoma Screening Is Associated With Increased Survival of Patients With Cirrhosis.
Choi DT; Kum HC; Park S; Ohsfeldt RL; Shen Y; Parikh ND; Singal AG
Clin Gastroenterol Hepatol; 2019 Apr; 17(5):976-987.e4. PubMed ID: 30616961
[TBL] [Abstract][Full Text] [Related]
12. Rate of hepatocellular carcinoma surveillance remains low for a large, real-life cohort of patients with hepatitis C cirrhosis.
Tran SA; Le A; Zhao C; Hoang J; Yasukawa LA; Weber S; Henry L; Nguyen MH
BMJ Open Gastroenterol; 2018; 5(1):e000192. PubMed ID: 29607053
[TBL] [Abstract][Full Text] [Related]
13. Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study.
Appel-da-Silva MC; Miozzo SA; Dossin IA; Tovo CV; Branco F; de Mattos AA
World J Gastroenterol; 2016 Dec; 22(46):10219-10225. PubMed ID: 28028370
[TBL] [Abstract][Full Text] [Related]
14. AGA Clinical Practice Update on Interaction Between Oral Direct-Acting Antivirals for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review.
Singal AG; Lim JK; Kanwal F
Gastroenterology; 2019 Jun; 156(8):2149-2157. PubMed ID: 30878469
[TBL] [Abstract][Full Text] [Related]
15. Golgi protein-73: A biomarker for assessing cirrhosis and prognosis of liver disease patients.
Gatselis NK; Tornai T; Shums Z; Zachou K; Saitis A; Gabeta S; Albesa R; Norman GL; Papp M; Dalekos GN
World J Gastroenterol; 2020 Sep; 26(34):5130-5145. PubMed ID: 32982114
[TBL] [Abstract][Full Text] [Related]
16. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
17. Imaging surveillance and multidisciplinary review improves curative therapy access and survival in HCC patients.
Gaba RC; Kallwitz ER; Parvinian A; Bui JT; Von Roenn NM; Berkes JL; Cotler SJ
Ann Hepatol; 2013; 12(5):766-73. PubMed ID: 24018494
[TBL] [Abstract][Full Text] [Related]
18. Benefits and Harms of Hepatocellular Carcinoma Surveillance in a Prospective Cohort of Patients With Cirrhosis.
Singal AG; Patibandla S; Obi J; Fullington H; Parikh ND; Yopp AC; Marrero JA
Clin Gastroenterol Hepatol; 2021 Sep; 19(9):1925-1932.e1. PubMed ID: 32920214
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Outcomes of Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma in the United States.
Karim MA; Singal AG; Kum HC; Lee YT; Park S; Rich NE; Noureddin M; Yang JD
Clin Gastroenterol Hepatol; 2023 Mar; 21(3):670-680.e18. PubMed ID: 35307595
[TBL] [Abstract][Full Text] [Related]
20. Improved Survival in At-Risk Patients Undergoing Surveillance for Hepatocellular Carcinoma - A Nationwide Swedish Register-Based Study.
Thörn R; Hemmingsson O; Danielsson Borssén Å; Werner M; Karling P; Wixner J
J Hepatocell Carcinoma; 2023; 10():1573-1586. PubMed ID: 37753268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
